European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Related Insights

Life Sciences & Pharma

On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (South Korea)

August 12, 2025

Executive Insights

Life Sciences & Pharma

How Pharma Companies Are Driving the Next Wave of Revenue Growth

June 25, 2025

Life Sciences & Pharma

Prescription for Progress: A Health Equity Maturity Framework for Pharma Companies

June 12, 2025

Video / Webinar

Life Sciences & Pharma

Why Health Equity Matters in Pharma

June 12, 2025

Published Articles

Life Sciences & Pharma

The Growth of Radiotherapeutics: Addressing Supply Chain Complexity

May 21, 2025

Executive Insights

Healthcare

The Race Is On: Winning Smart in the Intensifying GLP-1 Market in China

May 15, 2025